🇺🇸 FDA
Patent

US 10532059

Steroid hormone pharmaceutical composition

granted A61KA61K31/565A61K31/57

Quick answer

US patent 10532059 (Steroid hormone pharmaceutical composition) held by Compass Therapeutics LLC expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/565, A61K31/57, A61K47/06, A61K47/14